Immunovant, Inc. Share Price & Technical Analysis
IMVT · $31.15 (+0.74%)
Healthcare / Biotechnology
$31.15
+0.74%
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinati…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
-6% return in Jun, 1% avg return in past 3 year Jun month.
24% return in 2026, 28% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | 7% | -8% | 8% | 22% | -6% | – | – | – | – | – | – | 24% |
| 25 | -13% | -3% | -15% | -6% | -7% | 8% | 1% | -7% | 9% | 53% | -1% | 5% | 24% |
| 24 | -12% | -2% | -9% | -14% | -7% | 5% | 10% | 7% | -8% | 3% | -4% | -12% | -44% |
| 23 | -2% | -1% | -11% | 5% | 27% | -10% | 21% | 0% | 68% | -15% | 18% | 7% | 105% |
| 22 | -19% | -21% | -2% | -18% | -9% | -7% | 5% | 27% | 10% | 96% | 16% | 36% | 115% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Strong · Uptrend
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.34B
P/E ratio
—
52W high
$36.28
52W low
$14.32
Volume
18,50,851
Beta
0.70
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Immunovant, Inc. share price today?
- Immunovant, Inc. (IMVT) last traded around $31.15 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does IMVT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for IMVT. Download the app for real-time alerts.
- How can I analyze Immunovant, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.